CD274 and neoplasm: As shown in Figure 2(b), both PDL1-scFv-Fc-RE7 and PDL1-scFv-Fc chimeric proteins successfully bind to tumor cell with similar affinity to each other and the commercial anti-PD-L1 antibody.